Clinical Trials
A Phase I, Open-Label, Multinational, Multicenter, Dose Escalation and Expansion Study of BH3120 in Patients with Advanced or Metastatic Solid Tumors
ClinicalTrials.gov Identifier
ClinicalTrials.gov registration not required
Principal Investigator
John Sarantopoulos MD
For more information about this study
View DetailsAbout This Study
To evaluate the safety and tolerability of BH3120 administered intravenously (IV) in subjects with advanced or metastatic solid tumors.
Close
